Chance of Alzheimer's Disease Diagnosis is Higher in Older Adults with COVID-19
Data was collected by researchers to understand the underlying mechanisms and for continuous surveillance of long-term impacts of COVID-19 on Alzheimer’s disease.
Older adults with COVID-19 have a higher chance of being diagnosed with Alzheimer's disease, according to researchers at Case Western University.
Data was collected by researchers to understand the underlying mechanisms and for continuous surveillance of long-term impacts of COVID-19 on Alzheimer’s disease. It was then shared in a study recently published in the Journal of Alzheimer’s Disease.
The study reported that those 65 and older with COVID had more of a chance to develop Alzheimer's in the year following their COVID diagnosis. Patients most at threat were women 85 years and older.
These results were found and collected in the retrospective cohort study of over 6.2 million older adults 65 years and older who had medical encounters between February 2020 to May 2021.
Researchers used an analytics platform to access de-identified electronic health records of over 95 million patients of both inpatient and outpatient visits from 68 healthcare organizations, representing 28% of the U.S. population from 50 states covering different geographic, age, race/ethnic, income and insurance groups.
Data shared that the COVID-19 cohort did not differ in age nor gender from the non-COVID-19 cohort, but comprised more Hispanic and Black people and had higher prevalence of adverse socioeconomic determinants of health and comorbidities
However, whether COVID-19 might trigger new-onset Alzheimer’s disease or accelerate its emergence is unclear, the study said.
Researchers suggest the next steps in this investigation include validation from other data resources, longer-term follow-up, mechanism understanding and examining other types of dementia
Latest Vaccines and Antiviral Treatments Show Promising Results in Reducing Severe COVID Outcomes
March 7th 2024It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Read More
In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.
Listen
How More Prompt Action Could Have Saved Thousands of U.S. COVID-19 Deaths
December 10th 2023Researchers of a study compared Israel's CVOID-19 booster rollout experience to the United States to ask the question: How many lives could the U.S. have saved if boosters were authorized sooner?
Read More
Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.
Listen
A Cup or Two of Joe a Day Could Keep COVID-19 Infection Away
November 19th 2023Coffee, rich in polyphenolic compounds like chlorogenic acid (CGA), caffeic acid (CAA), cafestol, melanoidins and trigonelline, has been recognized as a dominant source of CGA in various studies. Previous studies suggest that CGA in coffee can positively impact blood pressure, lipid profile, glycemia and insulin resistance.
Read More
The Challenges, Strategies of COVID-19 Misinformation Interventions
November 16th 2023COVID-19 misinformation interventions should involve public health experts, establish consistent outcome measures and more to address health misinformation at individual, community and systems levels, according researchers of a recent study.
Read More
